Protalix BioTherapeutics, Inc. Company Profile
Protalix BioTherapeutics, Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, New Jersey, 07601, United States.
- Mailing address: Value 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, New Jersey, 07601, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, New Jersey, 07601, United States |
| Mailing address | 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, New Jersey, 07601, United States |
| Industry (SIC) | 2836 Biological Products, (No Diagnostic Substances) |
| Fiscal year end | 12-31 |
| Filer category | Non-accelerated filer<br>Smaller reporting company |
| Listed stock (Section 12(b)) | Common stock, $0.001 par value · PLX · NYSEAMER 10-Q filed 2026-08-12 cover |
| Shell company | No 10-Q filed 2026-08-12 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-12 cover |
| Emerging growth company | No 10-Q filed 2026-08-12 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-12 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-18 cover |
| Voluntary filer | No 10-K filed 2026-03-18 cover |
| Former names | ORTHODONTIX INC (1998-04-22 to 2007-02-22) EMBASSY ACQUISITION CORP (1996-08-13 to 1998-03-31) |
| First EDGAR filing | 1996-08-13 (10QSB) |
| SEC CIK | 1006281 |
| EIN | 650643773 |
| Phone | 201-696-9345 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |